CAS 2410957-04-7

Formule : C34H54N12O7

InChI : InChI=1S/C34H54N12O7/c1-18(2)27(32(52)43-24(29(35)49)14-21-15-39-17-41-21)46-31(51)25(13-20-8-10-22(47)11-9-20)44-33(53)28(19(3)4)45-30(50)23(42-26(48)16-38-5)7-6-12-40-34(36)37/h8-11,15,17-19,23-25,27-28,38,47H,6-7,12-14,16H2,1-5H3,(H2,35,49)(H,39,41)(H,42,48)(H,43,52)(H,44,53)(H,45,50)(H,46,51)(H4,36,37,40)/t23-,24-,25-,27-,28-/m0/s1

Code InChI : JZYGWEQFALQYNB-OQWKOXFXSA-N

SMILES : CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC

Pulchinenoside C

CAS : 2410957-04-7

Pulchinenoside C

Formule : C₅₉H₉₆O₂₆

Degré de pureté : ≥95%

Masse moléculaire : 1221.38

Ref: 54-BUP20550

TRV120055

CAS : 2410957-04-7

TRV120055

Formule : C₅₉H₉₆O₂₆

Degré de pureté : 99%

Masse moléculaire : 1221.38

Ref: 54-OR1174952

TRV120055

CAS : 2410957-04-7

TRV120055 is a Gq-biased agonist with 10x more efficacy on AT1R-Gq than AT1R-βarr2.

Formule : C₃₄H₅₄N₁₂O₇

Masse moléculaire : 742.8688

Ref: TM-T39995

TRV120055

CAS : 2410957-04-7

Formule : C₃₄H₅₄N₁₂O₇

Degré de pureté : 99%

Masse moléculaire : 742.8688

Ref: IN-DA01MVXG

TRV120055

CAS : 2410957-04-7

TRV120055 is a medicinal compound that acts as a kinase inhibitor, specifically targeting the cell cycle and protein synthesis in cancer cells. It has been shown to be effective against leukemia and various types of tumors in human and Chinese hamster cell lines. TRV120055 inhibits the activity of specific proteins involved in cancer cell growth and proliferation, leading to apoptosis or programmed cell death. This compound has potential as an anti-cancer drug due to its ability to selectively target cancer cells while leaving healthy cells unharmed. Its efficacy as a cancer treatment is currently being studied in clinical trials.

Formule : C₃₄H₅₄N₁₂O₇

Degré de pureté : Min. 95%

Masse moléculaire : 742.9 g/mol

Ref: 3D-KWD95704